DMCC Speciality Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 11:37 pm

Quick Insight

DMCC Speciality Chemicals Ltd, with a share price of 332 and a market capitalization of 829 Cr., exhibits a P/E ratio of 29.7, indicating investors' willingness to pay a premium for future earnings growth. The company's ROE stands at 9.87%, reflecting its ability to generate profit from shareholder equity, while the ROCE of 14.6% showcases efficient capital utilization. With a healthy OPM of 12.08% and a Net Profit of 22 Cr., DMCC demonstrates operational effectiveness. The company's strong balance sheet is evident through reserves of 202 Cr. and a manageable level of borrowings at ₹47 Cr. Shareholder distribution highlights promoter confidence at 53.84%, while institutional ownership is relatively low. The P/BV ratio of 3.29x suggests the stock may be trading at a premium relative to its book value. Overall, DMCC's financial indicators present a mixed picture, signaling potential for growth but warranting a closer look into operational efficiency and capital structure for informed investment decisions.

Competitors of DMCC Speciality Chemicals Ltd

All Competitor Stocks of DMCC Speciality Chemicals Ltd

Quarterly Result

Last Updated: August 19, 2025, 7:55 pm

Below is a detailed analysis of the quarterly data for DMCC Speciality Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 127.02 Cr.. The value appears strong and on an upward trend. It has increased from 125.19 Cr. (Mar 2025) to 127.02 Cr., marking an increase of 1.83 Cr..
• For Expenses, as of Jun 2025, the value is 110.14 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 110.07 Cr. (Mar 2025) to 110.14 Cr., marking an increase of 0.07 Cr..
• For Operating Profit, as of Jun 2025, the value is 16.88 Cr.. The value appears strong and on an upward trend. It has increased from 15.12 Cr. (Mar 2025) to 16.88 Cr., marking an increase of 1.76 Cr..
• For OPM %, as of Jun 2025, the value is 13.29%. The value appears strong and on an upward trend. It has increased from 12.08% (Mar 2025) to 13.29%, marking an increase of 1.21%.
• For Other Income, as of Jun 2025, the value is 0.37 Cr.. The value appears to be declining and may need further review. It has decreased from 0.44 Cr. (Mar 2025) to 0.37 Cr., marking a decrease of 0.07 Cr..
• For Interest, as of Jun 2025, the value is 2.03 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.19 Cr. (Mar 2025) to 2.03 Cr., marking a decrease of 0.16 Cr..
• For Depreciation, as of Jun 2025, the value is 4.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.03 Cr. (Mar 2025) to 4.19 Cr., marking an increase of 0.16 Cr..
• For Profit before tax, as of Jun 2025, the value is 11.03 Cr.. The value appears strong and on an upward trend. It has increased from 9.34 Cr. (Mar 2025) to 11.03 Cr., marking an increase of 1.69 Cr..
• For Tax %, as of Jun 2025, the value is 29.74%. The value appears to be improving (decreasing) as expected. It has decreased from 30.73% (Mar 2025) to 29.74%, marking a decrease of 0.99%.
• For Net Profit, as of Jun 2025, the value is 7.75 Cr.. The value appears strong and on an upward trend. It has increased from 6.47 Cr. (Mar 2025) to 7.75 Cr., marking an increase of 1.28 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.11. The value appears strong and on an upward trend. It has increased from 2.59 (Mar 2025) to 3.11, marking an increase of 0.52.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:47 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:25 pm

Below is a detailed analysis of the balance sheet data for DMCC Speciality Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 25.00 Cr..
• For Reserves, as of Mar 2025, the value is 202.00 Cr.. The value appears strong and on an upward trend. It has increased from 184.00 Cr. (Mar 2024) to 202.00 Cr., marking an increase of 18.00 Cr..
• For Borrowings, as of Mar 2025, the value is 47.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 88.00 Cr. (Mar 2024) to 47.00 Cr., marking a decrease of 41.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 106.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 80.00 Cr. (Mar 2024) to 106.00 Cr., marking an increase of 26.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 380.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 377.00 Cr. (Mar 2024) to 380.00 Cr., marking an increase of 3.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 234.00 Cr.. The value appears to be declining and may need further review. It has decreased from 238.00 Cr. (Mar 2024) to 234.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 6.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 145.00 Cr.. The value appears strong and on an upward trend. It has increased from 132.00 Cr. (Mar 2024) to 145.00 Cr., marking an increase of 13.00 Cr..
• For Total Assets, as of Mar 2025, the value is 380.00 Cr.. The value appears strong and on an upward trend. It has increased from 377.00 Cr. (Mar 2024) to 380.00 Cr., marking an increase of 3.00 Cr..

Notably, the Reserves (202.00 Cr.) exceed the Borrowings (47.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for DMCC Speciality Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
• For Diluted EPS (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
• For Cash EPS (Rs.), as of Mar 25, the value is 15.34. This value is within the healthy range. It has increased from 10.95 (Mar 24) to 15.34, marking an increase of 4.39.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.25. It has increased from 84.02 (Mar 24) to 91.25, marking an increase of 7.23.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 172.93. It has increased from 131.50 (Mar 24) to 172.93, marking an increase of 41.43.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 23.40. This value is within the healthy range. It has increased from 18.73 (Mar 24) to 23.40, marking an increase of 4.67.
• For PBIT / Share (Rs.), as of Mar 25, the value is 16.70. This value is within the healthy range. It has increased from 12.43 (Mar 24) to 16.70, marking an increase of 4.27.
• For PBT / Share (Rs.), as of Mar 25, the value is 12.48. This value is within the healthy range. It has increased from 6.92 (Mar 24) to 12.48, marking an increase of 5.56.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 8.63. This value is within the healthy range. It has increased from 4.65 (Mar 24) to 8.63, marking an increase of 3.98.
• For PBDIT Margin (%), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 14.24 (Mar 24) to 13.53, marking a decrease of 0.71.
• For PBIT Margin (%), as of Mar 25, the value is 9.65. This value is below the healthy minimum of 10. It has increased from 9.45 (Mar 24) to 9.65, marking an increase of 0.20.
• For PBT Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 10. It has increased from 5.26 (Mar 24) to 7.21, marking an increase of 1.95.
• For Net Profit Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 5. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 8. It has increased from 3.53 (Mar 24) to 4.99, marking an increase of 1.46.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.45. This value is below the healthy minimum of 15. It has increased from 5.53 (Mar 24) to 9.45, marking an increase of 3.92.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.38. This value is within the healthy range. It has increased from 11.47 (Mar 24) to 15.38, marking an increase of 3.91.
• For Return On Assets (%), as of Mar 25, the value is 5.66. This value is within the healthy range. It has increased from 3.07 (Mar 24) to 5.66, marking an increase of 2.59.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 0.2. It has decreased from 0.27 (Mar 24) to 0.17, marking a decrease of 0.10.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.20. This value is within the healthy range. It has decreased from 0.31 (Mar 24) to 0.20, marking a decrease of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.14. It has increased from 0.84 (Mar 24) to 1.14, marking an increase of 0.30.
• For Current Ratio (X), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 24) to 1.23, marking an increase of 0.15.
• For Quick Ratio (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.84, marking an increase of 0.18.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.98. This value is within the healthy range. It has increased from 4.03 (Mar 24) to 5.98, marking an increase of 1.95.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.56. This value is within the healthy range. It has increased from 3.40 (Mar 24) to 5.56, marking an increase of 2.16.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.05. This value is within the healthy range. It has increased from 1.84 (Mar 24) to 3.05, marking an increase of 1.21.
• For Enterprise Value (Cr.), as of Mar 25, the value is 789.57. It has increased from 745.75 (Mar 24) to 789.57, marking an increase of 43.82.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 2.27 (Mar 24) to 1.83, marking a decrease of 0.44.
• For EV / EBITDA (X), as of Mar 25, the value is 13.53. This value is within the healthy range. It has decreased from 15.96 (Mar 24) to 13.53, marking a decrease of 2.43.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 3.29. This value exceeds the healthy maximum of 3. It has increased from 3.27 (Mar 24) to 3.29, marking an increase of 0.02.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.74, marking a decrease of 0.35.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness